PDF(Pubmed)
Abstract：
May-Thurner syndrome (MTS) is a rare condition that increases the risk of left-sided iliofemoral venous thrombosis due to compression of the left common iliac vein by the right common iliac artery. Treatment for symptomatic MTS typically includes combined anticoagulation and endovascular therapy. This patient presented to the emergency department with acute left lower extremity pain and swelling. After imaging confirmed MTS, the patient was discharged from the ED and expeditiously treated in an office-based lab (OBL) setting with venous thrombectomy, angioplasty, and stenting. The setting where endovascular therapy is performed may significantly impact access to care for patients. Additionally, cost-effectiveness is a factor that should be considered when deciding the treatment site of service. We demonstrate the safety and cost-viability of performing venous thrombectomy, angioplasty, and stenting in an outpatient setting for the treatment of acute iliofemoral venous thrombosis.
摘要：
May-Thurner综合征（MTS）是一种罕见的疾病，由于右髂总动脉压迫左髂总静脉而增加了左侧髂股静脉血栓形成的风险。症状性MTS的治疗通常包括联合抗凝和血管内治疗。该患者因急性左下肢疼痛和肿胀而出现在急诊科。成像后确认MTS，患者已从ED出院，并在办公室实验室（OBL）中迅速接受静脉血栓切除术治疗，血管成形术,和支架。进行血管内治疗的设置可能会显著影响患者获得护理。此外,成本效益是在决定服务地点时应考虑的因素。我们证明了进行静脉血栓切除术的安全性和成本可行性，血管成形术,和支架在门诊设置治疗急性髂股静脉血栓形成。
